BACKGROUND: Atherosclerotic plaques demonstrate extensive accumulation of oxidative DNA damage, predominantly as 8-oxoguanine (8oxoG) lesions. 8oxoG is repaired by base excision repair enzymes; however, the mechanisms regulating 8oxoG accumulation in vascular smooth muscle cells (VSMCs) and its effects on their function and in atherosclerosis are unknown. METHODS: We studied levels of 8oxoG and its regulatory enzymes in human atherosclerosis, the mechanisms regulating 8oxoG repair and the base excision repair enzyme 8oxoG DNA glycosylase I (OGG1) in VSMCs in vitro, and the effects of reducing 8oxoG in VSMCs in atherosclerosis in ApoE-/- mice. RESULTS: Human plaque VSMCs showed defective nuclear 8oxoG repair, associated with reduced acetylat...
Background: Atherosclerosis progression during aging culminates in the development of vulnerable pla...
Although the hydroxymethylglutaryl-coenzyme A reductase inhibitors (statins) are widely used in athe...
Although the hydroxymethylglutaryl-coenzyme A reductase inhibitors (statins) are widely used in athe...
Background: Atherosclerotic plaques demonstrate extensive accumulation of oxidative DNA damage, pred...
Rationale: DNA damage and the DNA damage response (DDR) have been identified in human atherosclerosi...
Advanced atherosclerotic plaques demonstrate extensive DNA damage, seen in smooth muscle cells, endo...
RationaleActivation of NLRP3 (nucleotide-binding domain and leucine-rich repeat pyrin domain contain...
Cardiovascular diseases are one of the top causes of mortality worldwide, and the main underlying ca...
Background and aims: Atherogenesis involves a complex interaction between immune cells and lipids, p...
Rationale: DNA damage is present in both genomic and mitochondrial DNA in atherosclerosis. However, ...
Background—Vascular smooth muscle cells (VSMCs) in human atherosclerosis manifest extensive DNA dama...
Atherosclerosis is considered as a multifactorial disease in terms of the pathogenic mechanisms. Oxi...
Abstract DNA damage contributes to atherosclerosis. However, causative links between DNA double-stra...
Background—Mitochondrial DNA (mtDNA) damage occurs in both circulating cells and the vessel wall in ...
Atherosclerosis is considered as a multifactorial disease in terms of the pathogenic mechanisms. Oxi...
Background: Atherosclerosis progression during aging culminates in the development of vulnerable pla...
Although the hydroxymethylglutaryl-coenzyme A reductase inhibitors (statins) are widely used in athe...
Although the hydroxymethylglutaryl-coenzyme A reductase inhibitors (statins) are widely used in athe...
Background: Atherosclerotic plaques demonstrate extensive accumulation of oxidative DNA damage, pred...
Rationale: DNA damage and the DNA damage response (DDR) have been identified in human atherosclerosi...
Advanced atherosclerotic plaques demonstrate extensive DNA damage, seen in smooth muscle cells, endo...
RationaleActivation of NLRP3 (nucleotide-binding domain and leucine-rich repeat pyrin domain contain...
Cardiovascular diseases are one of the top causes of mortality worldwide, and the main underlying ca...
Background and aims: Atherogenesis involves a complex interaction between immune cells and lipids, p...
Rationale: DNA damage is present in both genomic and mitochondrial DNA in atherosclerosis. However, ...
Background—Vascular smooth muscle cells (VSMCs) in human atherosclerosis manifest extensive DNA dama...
Atherosclerosis is considered as a multifactorial disease in terms of the pathogenic mechanisms. Oxi...
Abstract DNA damage contributes to atherosclerosis. However, causative links between DNA double-stra...
Background—Mitochondrial DNA (mtDNA) damage occurs in both circulating cells and the vessel wall in ...
Atherosclerosis is considered as a multifactorial disease in terms of the pathogenic mechanisms. Oxi...
Background: Atherosclerosis progression during aging culminates in the development of vulnerable pla...
Although the hydroxymethylglutaryl-coenzyme A reductase inhibitors (statins) are widely used in athe...
Although the hydroxymethylglutaryl-coenzyme A reductase inhibitors (statins) are widely used in athe...